Approval of the first H.I.V. preventive has tangled experts in complicated scientific and psychological issues and brought sometimes furious debate. One side says people are so unlikely to use the drug properly that it is irresponsible and dangerous to let them have it. The other side calls that argument paternalistic and says people who are motivated to protect themselves should be given the tools to do so...